University Of Iowa is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The University of Iowa (UIowa) is a major research university with a distinguished history in neuroscience and neurodegenerative disease research. Located in Iowa City, the university is home to the Iowa Neuroscience Institute and the Roy J. and Lucille A. Carver College of Medicine, which host world-class programs investigating Alzheimer's disease, Parkinson's disease, ALS, Huntington's disease, and other neurodegenerative disorders. [1]
| Attribute | Details | [2]
|-----------|---------| [3]
| Full Name | University of Iowa | [4]
| Location | Iowa City, Iowa, USA | [5]
| Type | Public Research University (Ivy) | [6]
| Founded | 1847 |
| Enrollment | ~30,000 students |
| Website | uiowa.edu |
The University of Iowa was founded in 1847 as the first public university in the United States to admit men and women on equal terms. The Carver College of Medicine was established in 1870, and the university has been at the forefront of medical research ever since. The Iowa Neuroscience Institute was founded in 2015 under the leadership of Dr. Ted Abel, bringing together over 60 faculty members from various departments to study the nervous system and neurological diseases.
The university's Department of Neurology has a long-standing tradition of excellence in neurodegenerative disease research, dating back to the early studies on Huntington's disease in the 1970s. Today, UIowa is recognized as a Huntington's Disease Society of America Center of Excellence and participates in numerous clinical trials for AD, PD, and ALS.
Founded in 2015, the Iowa Neuroscience Institute brings together over 60 faculty members studying:
The UIowa Center for Neurodegeneration focuses on:
UIowa has a long-standing HD research program, designated as a Huntington's Disease Society of America Center of Excellence:
The Paulson Lab specializes in prion diseases and protein aggregation:
| Disease | Research Intensity |
|---|---|
| Parkinson's Disease | High |
| Alzheimer's Disease | High |
| Huntington's Disease | High |
| ALS | Moderate-High |
| Frontotemporal Dementia | Moderate |
| Prion Diseases | Moderate |
The study of University Of Iowa has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Guo JL, et al. Coillision of alpha-synuclein and tau pathology in neurodegenerative diseases. Neuron. 2018. ↩︎
Pieper AA, et al. Discovery of neuroprotective small molecules for neurodegenerative diseases. Neuron. 2019. ↩︎
Cook C, et al. Tau pathology in Alzheimer's disease and related disorders. Acta Neuropathol. 2020. ↩︎
Paulson HL, et al. Prion diseases and protein aggregation. Handb Clin Neurol. 2017. ↩︎
Harper SM, et al. RNA metabolism in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Rev Neurol. 2021. ↩︎
University of Iowa Neurology Annual Research Reports 2020-2024. 2020. ↩︎